SENSORMATIC-SOLUTIONS
12.2.2020 08:02:09 CET | Business Wire | Press release
Johnson Controls announced today its leading global retail solutions portfolio, Sensormatic Solutions , will showcase its latest product innovations at EuroShop 2020 , 16-20 February 2020 at the Düsseldorf Exhibition Centre in Germany. By combining insights into retail inventory, shopper traffic and loss prevention, Sensormatic Solutions powers operational excellence at scale and helps retailers create unique shopper experiences.
Sensormatic Solutions continues to fast forward retail with its portfolio of smart, connected and scalable solutions. The technologies that will be on display at this year’s show leverage the latest in Artificial Intelligence (AI), Machine Learning (ML), smart sensors, and video analytics, and bring to life the new collaboration with Intel Corporation.
Sensormatic Solutions is now working with Intel to deliver scalable, AI-powered solutions for retailers. At EuroShop, the companies will showcase the Computer Vision Platform, which leverages Intel® OpenVINO™ and the Sensormatic Smart Hub and Artificial Intelligence Camera developed collaboratively with Intel for the edge. The following solutions will be on display:
- Exterior Store Analytics – Gain shopper journey visibility into blind spots in queue analytics and the quick service restaurants (QSR) industry using computer vision object detection and tracking technology. Analytics and insights will cover a shopper’s digital brand touch points while online through in store order fulfillment.
- Unified Commerce – Experience improved visibility into real-time inventory information, the foundation of today’s world of unified commerce. Radio-frequency identification-enabled (RFID) cycle counting, interactive restocking and inventory analytics help retailers know exactly what merchandise is available on the sales floor, stock room and other zones for efficient unified commerce execution and a frictionless shopper experience. TrueVUE Cloud enables buy online, pickup in store (BOPIS) tasks through automatic order notification, picking and fulfillment features that allow customers to shop anywhere, anytime. Sure Zone, the latest innovation from TrueVUE Cloud, provides retailers with consistently high inventory accuracy without the need to shield their stores. This RFID inventory management solution not only produces consistently more accurate cycle counts but generates a greater ROI and faster store deployments.
- AI Data Intelligence – Insights platform complete with computer vision, data, AI and machine learning technology that delivers data-driven prescriptive actions to help improve retailers’ performance. Benefiting from our new technology collaboration with Intel, this solution leverages store-level source data related to shopper traffic, inventory position, and loss prevention, and helps drive targeted behavior to improve store operations.
- AI Vision Intelligence – The AI Vision Intelligence demo will show how to drive targeted behavior to improve store operations and shopper experience. It encompasses deep learning models, image processing and the AI camera developed with Intel to assess associates’ responsiveness to customers and measure how customers interact with merchandise and more.
- Shopper Engagement – The Shopper Engagement demo is intended to help provide actionable insights regarding shopper behaviors along the shopping journey. Combined with the AI camera developed collaboratively with Intel, Sensormatic Solutions technology enables retailers to gain real-time visibility and predictive analytics for accurate decision making. The solution will provide real-time information regarding inventory levels dropping below defined goals, out of stock conditions by SKU, and shoppers’ viewing and interactions with merchandise.
- Dynamic Content Delivery – In partnership with VSBLTY, a leading software technology company, Dynamic Content Delivery will showcase retail solutions that leverage camera and sensor technology with AI to provide real-time analytics and audience measurement. The VSBLTY solution brings the advantage of online advertising into the brick and mortar landscape with systems that integrate signage, security and analytics.
These innovations and more will be showcased at EuroShop 2020 trade show in Düsseldorf, Germany. Visit us in Hall 6, Stand C01 between 16-20 February to see firsthand how inventory, loss prevention and shopper traffic solutions fast forward retail and enable smart, connected shopper engagement.
To experience firsthand how our solutions come into play on a customer level, please visit our special presentation “How ShopperTrak’s data analytics proved commercial success of Designer Outlet Croatia” on Retail Technology Stage on Sunday, 16th February 2020 at 11 a.m. Thomas Hillebrand, General Manager Europe and Global Accounts at ShopperTrak, part of Sensormatic Solutions, will focus on a recent project – Designer Outlet Croatia and IngKa Centres – which reveals how traffic data insights are being used to measure the success of a unique hybrid development - and drive improvements.
About Johnson Controls
At Johnson Controls, we transform the environments where people live, work, learn and play. From optimizing building performance to improving safety and enhancing comfort, we drive the outcomes that matter most. We deliver our promise in industries such as healthcare, education, data centers and manufacturing. With a global team of 105,000 experts in more than 150 countries and over 130 years of innovation, we are the power behind our customers’ mission. Our leading portfolio of building technology and solutions includes some of the most trusted names in the industry, such as Tyco®
, York®
, Metasys®
, Ruskin®
, Titus®
, Frick®
, Penn®
, Sabroe®
, Simplex®
, Ansul®
and Grinnell®
. For more information, visit www.johnsoncontrols.com
or follow us @johnsoncontrols on Twitter.
About Sensormatic Solutions
Sensormatic Solutions is the leading global retail solutions portfolio of Johnson Controls enabling smart and connected shopper engagement. By combining critical insights into retail inventory, shopper traffic and loss prevention, Sensormatic Solutions powers operational excellence at scale and helps create unique shopping experiences. Our solutions deliver real-time visibility and predictive analytics for accurate decision-making across the enterprise, enabling retailers to confidently move into the future. With more than 1.5 million data collection devices in the retail marketplace, we capture 40 billion shopper visits and track and protect billions of items each year. Our retail portfolio features the premier Sensormatic, ShopperTrak and TrueVUE brands. Please visit http://www.sensormatic.com
, or follow us on LinkedIn
, Twitter
, and our YouTube channel
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200211006075/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom